James H Stanker

PCSA

James H Stanker serves as Chief Financial Officer at Processa Pharmaceuticals, Inc. (PCSA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$6.8K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$6.8K

Companies Traded

PCSA

Active Period

Jun 2021

1 total trades

Most Recent

Buy PCSA

Jun 22, 2021 · $6.8K

James H Stanker's Insider Trading at Processa Pharmaceuticals, Inc. (PCSA)

Buys

1 · $6.8K

Sells

0 · $0.00

Total Shares Bought

1,000

Total Shares Sold

PCSA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 22, 2021	Buy	1,000	$6.81	$6.8K	36,510

Related Insiders

David Young

director, officer: Pres. Research & Development

PCSABuy · Apr 17, 2026

Sian Bigora

officer: Chief Development Officer

PCSABuy · Apr 17, 2026

Wendy Guy

officer: Chief Administrative Officer

PCSABuy · Apr 17, 2026

Patrick Lin

officer: Chief Business - Strategy Off

PCSABuy · Apr 17, 2026

George K Ng

director, officer: Chief Executive Officer

PCSABuy · Apr 17, 2026

SKIBSTED RUSSELL

officer: Chief Financial Officer

PCSABuy · Apr 17, 2026

Khoso Baluch

director

PCSABuy · Apr 1, 2026

Geraldine Pannu

director

PCSABuy · Apr 1, 2026

Explore More Insider Trading Data

PCSA Insider Trading Activity

View all insider trades at Processa Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity